Latest Breaking News On - Kiniksa pharmaceuticals ltd - Page 3 : comparemela.com

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaKiniksa pharmaceuticals stock performanceKiniksa pharmaceuticals ltdAllspring global investments holdingsHennion walsh asset management incSecurities exchange commissionInstitutional trading of kiniksa pharmaceuticalsKiniksa pharmaceuticals company profileKiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyParkman healthcare partnersGranahan investment managementOpaleye management incGet free reportExchange commissionGlobal investments holdings

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaSanjk patelPrincipal financial group incInsider transactions at kiniksa pharmaceuticalsSecurities exchange commissionLinden thomas advisory servicesChina universal asset management coConnor clark lunn investment management ltdKiniksa pharmaceuticals stock performanceKiniksa pharmaceuticals ltdAlps advisors incInstitutional investors weigh in on kiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticalsGet free reportExchange commission

Linden Thomas Advisory Services LLC Has $2 01 Million Holdings in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Linden Thomas Advisory Services LLC cut its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,550 shares of the company’s stock after selling 1,341 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Kiniksa Pharmaceuticals were worth $2,009,000 as of […]

Sanjk patelNews ratings for kiniksa pharmaceuticals dailyAcadian asset managementConnor clark lunn investment management ltdSchonfeld strategic advisorsQuarter for kiniksa pharmaceuticalsKiniksa pharmaceuticals company profileKiniksa pharmaceuticals stockLinden thomas advisory servicesSecurities exchange commissionInsider transactions at kiniksa pharmaceuticalsKiniksa pharmaceuticals ltdExchange commissionYork mellon corpKiniksa pharmaceuticalsBarclays plc

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results And Recent Portfolio Execution

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results And Recent Portfolio Execution
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomSanjk patelDrug administrationExchange commissionAmerican college of cardiology scientific sessionKiniksa pharmaceuticals ltdEuropean commissionRegeneron pharmaceuticals incAbiprubart phaseChief executive officerAmerican collegeCardiology scientific sessionRegeneron pharmaceuticalsFamilial cold autoinflammatory syndromeMuckle wells syndromeBreakthrough therapy

Linden Thomas Advisory Services LLC Reduces Holdings in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Linden Thomas Advisory Services LLC trimmed its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,550 shares of the company’s stock after selling 1,341 shares during […]

Michaelr megnaSanjk patelLinden thomas advisory servicesSecurities exchange commissionQuarter for kiniksa pharmaceuticalsKiniksa pharmaceuticalsKiniksa pharmaceuticals ltdKiniksa pharmaceuticals tradingExchange commissionAlps advisors incNews ratings for kiniksa pharmaceuticals dailyPrincipal financial group incChina universal asset management coSchonfeld strategic advisorsConnor clark lunn investment management ltdFree report